Pharmaceuticals, Biotechnology and Life Sciences
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the first quarter ended March 31, 2019, as…
Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $0.13…
DUBLIN–(BUSINESS WIRE)–The “Smoothened Homolog (Protein Gx or SMO) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Hypoglycemia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
Quarterly net revenues of $73.3 million, representing 41 percent growth versus the first quarter 2018 and 5 percent growth versus…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. Alzheimer’s disease…
DUBLIN–(BUSINESS WIRE)–The “Chronic Kidney Disease: Global Markets and Technologies Through 2023” report has been added to ResearchAndMarkets.com’s offering. The focus…
Results of a new survey show that even among patients at highest risk for nonalcoholic steatohepatitis (NASH), awareness of the…
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
Transgeen in agreement with AstraZeneca to co-developfive armed oncolytic vaccinia virus candidates. Innovative oncolyticviruses resulting from this collaboration will use Transgene’sproprietary next generation viral platform Invir.IO